Genital Psoriasis

Serious skin reactions linked to TNF-alpha antagonists - Xagena Medical News

noreply@blogger.com (MarcoPolo) — Thu, 11 Mar 2010 19:08:00 +0000

Safety reviews of tumor necrosis factor-alpha ( TNF-a ) antagonists, Infliximab ( Remicade ), Etanercept ( Enbrel ), and Adalimumab ( Humira ) identified rare cases of serious skin More Here

Safety reviews of tumor necrosis factor-alpha ( TNF-a ) antagonists, Infliximab ( Remicade ), Etanercept ( Enbrel ), and Adalimumab ( Humira ) identified rare cases of serious skin More Here

11

noreply@blogger.com (MarcoPolo) — Mon, 08 Mar 2010 19:08:00 +0000

1
1

Popular Alternative Therapy For Psoriasis Performs No Better Than Placebo

noreply@blogger.com (MarcoPolo) — Sat, 06 Mar 2010 01:08:00 +0000

Popular Alternative Therapy For Psoriasis Performs No Better Than Placebo
Anecdotal evidence touting the healing power of the Indian spice turmeric for psoriasis received a setback in a prospective study published in a dermatology journal stating that the low response rate of patients who ingested the active ingredient of the exotic spice was probably a result of the placebo effect.

Rash
Title: Rash
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 2/24/2010

Psoriasis Associated With Cardiovascular Disease And Increased Mortality
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death, according to a new article.

Popular Alternative Therapy For Psoriasis Performs No Better Than Placebo
Anecdotal evidence touting the healing power of the Indian spice turmeric for psoriasis received a setback in a prospective study published in a dermatology journal stating that the low response rate of patients who ingested the active ingredient of the exotic spice was probably a result of the placebo effect.

Rash
Title: Rash
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 2/24/2010

Psoriasis Associated With Cardiovascular Disease And Increased Mortality
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death, according to a new article.

11

noreply@blogger.com (MarcoPolo) — Wed, 03 Mar 2010 17:09:00 +0000

1
1

Shining secret that makes silver precious for your health - Daily Mail

noreply@blogger.com (MarcoPolo) — Mon, 01 Mar 2010 03:08:00 +0000

Shining secret that makes silver precious for your health - Daily Mail
Before the discovery of antibiotics, surgeons used to stitch wounds with thread woven with silver as they believed it helped to prevent infection. Meanwhile, bandages were laced

Shining secret that makes silver precious for your health - Daily Mail
Before the discovery of antibiotics, surgeons used to stitch wounds with thread woven with silver as they believed it helped to prevent infection. Meanwhile, bandages were laced

Study: Smoking Causes SIDS - Momlogic.com

noreply@blogger.com (MarcoPolo) — Fri, 26 Feb 2010 01:08:00 +0000

Everybody knows smoking is bad for you, especially when you're pregnant, yet there are still pregnant women smoking -- and many are unaware that can cause SIDS. The study found Read More .

Everybody knows smoking is bad for you, especially when you're pregnant, yet there are still pregnant women smoking -- and many are unaware that can cause SIDS. The study found Read More .

11

noreply@blogger.com (MarcoPolo) — Tue, 23 Feb 2010 13:08:00 +0000

1
1

11

noreply@blogger.com (MarcoPolo) — Sun, 21 Feb 2010 11:08:00 +0000

1
1

Dry Skin

noreply@blogger.com (MarcoPolo) — Tue, 16 Feb 2010 07:08:00 +0000

Dry Skin
Title: Dry Skin
Category: Diseases and Conditions
Created: 2/5/2010 5:21:00 PM
Last Editorial Review: 2/5/2010 5:21:00 PM

Health Tip: What May Cause Swelling
Title: Health Tip: What May Cause Swelling
Category: Health News
Created: 1/25/2010 8:10:00 AM
Last Editorial Review: 1/25/2010

Dry Skin
Title: Dry Skin
Category: Diseases and Conditions
Created: 2/5/2010 5:21:00 PM
Last Editorial Review: 2/5/2010 5:21:00 PM

Health Tip: What May Cause Swelling
Title: Health Tip: What May Cause Swelling
Category: Health News
Created: 1/25/2010 8:10:00 AM
Last Editorial Review: 1/25/2010

Psoriasis Drug Effective In Children And Adults, Study Suggests

noreply@blogger.com (MarcoPolo) — Thu, 11 Feb 2010 13:08:00 +0000

Psoriasis Drug Effective In Children And Adults, Study Suggests
College student Maria Anichini no longer has to hide her skin under long sleeves and pants. Her skin and life have rebounded since she became part of a trial testing an injectable drug for children and adolescents with psoriasis, a common skin disease causing red scaly patches all over the body. Researchers report the drug etanercept -- FDA approved for adults but never before tested in children for psoriasis-- dramatically reduced psoriasis flare-ups.
Source: www.sciencedaily.com

Scientists Unmask Genetic Markers Associated With Psoriasis
Scientists have found DNA "hotspots" that may reveal how genetic differences among individuals result in psoriasis, an autoimmune disease of the skin. The findings could lead to new drug targets and tailored treatments for the disease.
Source: www.sciencedaily.com

Green Tea May Delay Onset Of Type 1 Diabetes
A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say. Researchers were testing EGCG, green tea's predominant antioxidant, in a laboratory mouse with type 1 diabetes and primary Sjogren's syndrome, which damages moisture-producing glands, causing dry mouth and eyes.
Source: www.sciencedaily.com

Popular Alternative Therapy For Psoriasis Performs No Better Than Placebo
Anecdotal evidence touting the healing power of the Indian spice turmeric for psoriasis received a setback in a prospective study published in a dermatology journal stating that the low response rate of patients who ingested the active ingredient of the exotic spice was probably a result of the placebo effect.
Source: www.sciencedaily.com

Psoriasis Drug Effective In Children And Adults, Study Suggests
College student Maria Anichini no longer has to hide her skin under long sleeves and pants. Her skin and life have rebounded since she became part of a trial testing an injectable drug for children and adolescents with psoriasis, a common skin disease causing red scaly patches all over the body. Researchers report the drug etanercept -- FDA approved for adults but never before tested in children for psoriasis-- dramatically reduced psoriasis flare-ups.
Source: www.sciencedaily.com

Scientists Unmask Genetic Markers Associated With Psoriasis
Scientists have found DNA "hotspots" that may reveal how genetic differences among individuals result in psoriasis, an autoimmune disease of the skin. The findings could lead to new drug targets and tailored treatments for the disease.
Source: www.sciencedaily.com

Green Tea May Delay Onset Of Type 1 Diabetes
A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say. Researchers were testing EGCG, green tea's predominant antioxidant, in a laboratory mouse with type 1 diabetes and primary Sjogren's syndrome, which damages moisture-producing glands, causing dry mouth and eyes.
Source: www.sciencedaily.com

Popular Alternative Therapy For Psoriasis Performs No Better Than Placebo
Anecdotal evidence touting the healing power of the Indian spice turmeric for psoriasis received a setback in a prospective study published in a dermatology journal stating that the low response rate of patients who ingested the active ingredient of the exotic spice was probably a result of the placebo effect.
Source: www.sciencedaily.com

Genomic differences identified in common skin diseases may lead to better treatments

noreply@blogger.com (MarcoPolo) — Tue, 09 Feb 2010 07:09:00 +0000

Genomic differences identified in common skin diseases may lead to better treatments
Scientists have drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability to distinguish between the disorders' genetic and immunological signatures opens the door for more narrowly targeted therapies sorely needed by the millions of people afflicted worldwide.

'Master Regulator' Of Skin Formation Discovered
Researchers have found one gene in the human body that appears to be a master regulator for skin development, in research that could help address everything from skin diseases such as eczema or psoriasis to the wrinkling of skin as people age.

Patients Not Complying With Treatment A Universal Problem
Patients not complying with their dermatologic treatment is a universal problem that doctors need to address, according to Steven Feldman, M.D., Ph.D., from Wake Forest University School of Medicine in an editorial published in the current issue of Archives of Dermatology. He said non-compliance can explain why some conditions may seem resistant to treatment.

Genomic differences identified in common skin diseases may lead to better treatments
Scientists have drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability to distinguish between the disorders' genetic and immunological signatures opens the door for more narrowly targeted therapies sorely needed by the millions of people afflicted worldwide.

'Master Regulator' Of Skin Formation Discovered
Researchers have found one gene in the human body that appears to be a master regulator for skin development, in research that could help address everything from skin diseases such as eczema or psoriasis to the wrinkling of skin as people age.

Patients Not Complying With Treatment A Universal Problem
Patients not complying with their dermatologic treatment is a universal problem that doctors need to address, according to Steven Feldman, M.D., Ph.D., from Wake Forest University School of Medicine in an editorial published in the current issue of Archives of Dermatology. He said non-compliance can explain why some conditions may seem resistant to treatment.

Stelara produces promising results in trial; Evotec, CHDI extend Huntington's ... - FierceBiotech

noreply@blogger.com (MarcoPolo) — Wed, 03 Feb 2010 13:08:00 +0000

Stelara produces promising results in trial; Evotec, CHDI extend Huntington's ... - FierceBiotech

Stelara produces promising results in trial; Evotec, CHDI extend Huntington's ...
FierceBiotech
The first-of-its-kind head-to-head study comparing two biologic agents for plaque psoriasis also shows the efficacy of Stelara among patients in the study ...

and more »

Source: news.google.com

Stelara produces promising results in trial; Evotec, CHDI extend Huntington's ... - FierceBiotech

Source: news.google.com

Doctor presents psoriasis seminar - YourWestValley.com

noreply@blogger.com (MarcoPolo) — Sun, 31 Jan 2010 21:08:00 +0000

Doctor presents psoriasis seminar - YourWestValley.com

Doctor presents psoriasis seminar
YourWestValley.com
Dermatologist Keith J. Haar, who has a practice in Peoria, will have a free seminar to talk about living with psoriasis and how best to treat it. ...

Source: news.google.com

Vascular Biogenics refocuses on psoriasis drug clinical trial - Globes

Vascular Biogenics refocuses on psoriasis drug clinical trial
Globes
The change of direction has come about, firstly because of good results in the Phase I trial for the psoriasis treatment. ...

Source: news.google.com

Mitsubishi Tanabe Pharma wins approval for new indication of psoriasis drug - Trading Markets (press release)

Mitsubishi Tanabe Pharma wins approval for new indication of psoriasis drug
Trading Markets (press release)
Mitsubishi Tanabe Pharma has received the approval for additional indication of psoriasis for Remicade IV drip infusion 100, anti-human TNF-alpha monoclonal ...

and more »

Source: news.google.com

Using Massage Therapy to Help Psoriatic Arthritis - Institute for Integrative Healthcare Studies

Using Massage Therapy to Help Psoriatic Arthritis
Institute for Integrative Healthcare Studies
Before a client with psoriatic arthritis comes to you seeking relief, make sure you know about this condition and understand when massage might aggravate ...

and more »

Source: news.google.com

Severe form of psoriasis ups heart disease risk - Reuters

AsiaOne

Severe form of psoriasis ups heart disease risk
Reuters
NEW YORK (Reuters Health) - People with severe forms of the inflammatory skin disease psoriasis are more likely to die of heart-related causes and stroke ...
Severe psoriasis ups heart disease riskPress TV

all 14 news articles »

Source: news.google.com

Doctor presents psoriasis seminar - YourWestValley.com

Source: news.google.com

Vascular Biogenics refocuses on psoriasis drug clinical trial - Globes

Source: news.google.com

Mitsubishi Tanabe Pharma wins approval for new indication of psoriasis drug - Trading Markets (press release)

Source: news.google.com

Using Massage Therapy to Help Psoriatic Arthritis - Institute for Integrative Healthcare Studies

Source: news.google.com

Severe form of psoriasis ups heart disease risk - Reuters

AsiaOne

Source: news.google.com

Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up

noreply@blogger.com (MarcoPolo) — Wed, 27 Jan 2010 01:08:00 +0000

Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Conditions: Cardiovascular Diseases; Carotid Artery Diseases; Intracranial Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular Diseases; Atherosclerosis
Interventions: Drug: Vitamin E; Drug: Vitamin C
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified October 2006

Compromised Skin Barrier Function Plays A Role In Psoriasis Development
New research on genetic basis of psoriasis may prove important for early diagnosis and prediction of an individual's risk for this common chronic skin disease.

Pinning Down A Cause Of Disease In A Model Of Psoriasis
Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease.

Psoriasis drugs put to the test
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.

Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Conditions: Cardiovascular Diseases; Carotid Artery Diseases; Intracranial Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular Diseases; Atherosclerosis
Interventions: Drug: Vitamin E; Drug: Vitamin C
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified October 2006

Compromised Skin Barrier Function Plays A Role In Psoriasis Development
New research on genetic basis of psoriasis may prove important for early diagnosis and prediction of an individual's risk for this common chronic skin disease.

Pinning Down A Cause Of Disease In A Model Of Psoriasis
Psoriasis is a chronic skin disease that affects approximately 2--3% of individuals in the Western world. New data have indicated that a subset of immune cells known as Tregs (which act to prevent other immune cells from responding inappropriately) are dysfunctional in a mouse model of psoriasis and that this dysfunction contributes substantially to the development of disease.

Psoriasis drugs put to the test
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition.

11

noreply@blogger.com (MarcoPolo) — Sun, 17 Jan 2010 19:08:00 +0000

1
1

11

noreply@blogger.com (MarcoPolo) — Thu, 14 Jan 2010 13:05:00 +0000

1
1

11

noreply@blogger.com (MarcoPolo) — Sat, 09 Jan 2010 05:05:00 +0000

1
1

Celgene's Psoriasis Treatment Performs Well In Midstage Study - NASDAQ

noreply@blogger.com (MarcoPolo) — Tue, 22 Dec 2009 05:06:00 +0000

Celgene's Psoriasis Treatment Performs Well In Midstage Study - NASDAQ
Celgene Corp.'s (CELG) treatment for moderate-to-severe plaque-type psoriasis performed better than a placebo in a midstage clinical trial, suggesting it holds promise as an oral treatment. In a study of 352 patients, 41% of those receiving the
Source: www.nasdaq.com

Celgene's Psoriasis Treatment Performs Well In Midstage Study - NASDAQ
Celgene Corp.'s (CELG) treatment for moderate-to-severe plaque-type psoriasis performed better than a placebo in a midstage clinical trial, suggesting it holds promise as an oral treatment. In a study of 352 patients, 41% of those receiving the
Source: www.nasdaq.com

Experts Turn To Web To Combat Distressing Skin Disease

noreply@blogger.com (MarcoPolo) — Sun, 20 Dec 2009 01:05:00 +0000

People experiencing the skin disease psoriasis may get relief from their symptoms and the psychological distress they can cause through a new web-based therapy program. Read On Here.....

People experiencing the skin disease psoriasis may get relief from their symptoms and the psychological distress they can cause through a new web-based therapy program. Read On Here.....

11

noreply@blogger.com (MarcoPolo) — Thu, 17 Dec 2009 13:05:00 +0000

1
1

11

noreply@blogger.com (MarcoPolo) — Tue, 15 Dec 2009 09:05:00 +0000

1
1

11

noreply@blogger.com (MarcoPolo) — Thu, 03 Dec 2009 05:06:00 +0000

1
1

Living With Psoriasis

noreply@blogger.com (MarcoPolo) — Mon, 30 Nov 2009 23:03:00 +0000

Living With Psoriasis
Psoriasis is a difficult to treat (chronic relapsing) disease that affects the skin and occasionally the joints. About 2 % of the population will have the disease...
Source: ____http

Living With Psoriasis
Psoriasis is a difficult to treat (chronic relapsing) disease that affects the skin and occasionally the joints. About 2 % of the population will have the disease...
Source: ____http

New Skin-healing Chemicals

noreply@blogger.com (MarcoPolo) — Sun, 22 Nov 2009 17:06:00 +0000

Researchers have made synthetic lipids called pseudoceramides that are involved in skin cell growth and could be used in treating skin diseases in which skin cells grow abnormally. Ceramides are lipids found in the outermost skin layer called the stratum corneum, which is made of dead skin cells and mainly serves as a physical barrier. Ceramides' main biological function is to control how skin cells grow and differentiate -- a process through which skin cells become specialized. Read More....

Scientists find that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. Read More....

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers recently announced. Read More....

Researchers have made synthetic lipids called pseudoceramides that are involved in skin cell growth and could be used in treating skin diseases in which skin cells grow abnormally. Ceramides are lipids found in the outermost skin layer called the stratum corneum, which is made of dead skin cells and mainly serves as a physical barrier. Ceramides' main biological function is to control how skin cells grow and differentiate -- a process through which skin cells become specialized. Read More....

Scientists find that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. Read More....

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers recently announced. Read More....

11

noreply@blogger.com (MarcoPolo) — Fri, 20 Nov 2009 15:07:00 +0000

1
1